LIVELMIA is a revolutionary assay for nucleic acids analysis developed in the last 6 years of high-risk research. Our innovation enables our product to outperform the competing solutions addressing key user needs, boosting nucleic acids research in very important fields of medicine. The novelty of the LIVELMIA is based on the unique design of our probes for high specificity and sensitivity in targeting specific nucleic acids.